Grantham, Mayo, Van Otterloo & Co (GMO)’s Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs) MTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,900
Closed -$5K 804
2022
Q3
$5K Sell
26,900
-512,200
-95% -$95.2K ﹤0.01% 712
2022
Q2
$171K Hold
539,100
﹤0.01% 720
2022
Q1
$12K Buy
539,100
+171,700
+47% +$544K ﹤0.01% 685
2021
Q4
$1.17M Buy
+367,400
New +$1.35M 0.01% 525
2013
Q3
Sell
-8,810
Closed -$51K 739
2013
Q2
$51K Buy
+8,810
New +$64.3K ﹤0.01% 643

Other funds holding MTL

Grantham, Mayo, Van Otterloo & Co (GMO)'s MTL Position: Q4 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs) (MTL) in Q4 2022, closing a stake of 26,900 shares — an estimated $5K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MTL in Q2 2013 and held it in 5 quarters. The position peaked at $1.17M in Q4 2021. 7 funds tracked by Wall St. Rank hold MTL as of Q4 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs) position as of Q4 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 26,900 Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs) shares in Q4 2022, an estimated $5K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs) in Q2 2013 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs) position peaked at $1.17M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs) as of Q4 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.